Effectiveness of Elbasvir/Grazoprevir in US Veterans with Chronic Hepatitis C Virus Genotype 1b Infection
Abstract Introduction Real-world treatment of hepatitis C virus (HCV) infection is complicated by many factors that are controlled for in the rigorous clinical trial setting. The aim of the present study was to assess the efficacy of elbasvir/grazoprevir in a Veterans Affairs population with chronic...
Main Authors: | Amy Puenpatom, Yumei Cao, Xian Yu, Fasiha Kanwal, Hashem B. El-Serag, Jennifer R. Kramer |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-04-01
|
Series: | Infectious Diseases and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40121-020-00293-7 |
Similar Items
-
Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial
by: Zhdanov K, et al.
Published: (2020-04-01) -
Meta-Analysis of Grazoprevir plus Elbasvir for Treatment of Hepatitis C Virus Genotype 1 Infection
by: Hussien Ahmed, et al.
Published: (2018-01-01) -
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
by: Youn Jae Lee, et al.
Published: (2019-12-01) -
Spotlight on grazoprevir—elbasvir once-daily combination and its potential in the treatment of hepatitis C
by: Suraweera D, et al.
Published: (2016-06-01) -
Elbasvir/grazoprevir treatment in an HCV-infected peritoneal dialysis patient
by: Jin Chen, et al.
Published: (2020-01-01)